Cargando…

Resistome analysis of Mycobacterium tuberculosis: Identification of aminoglycoside 2'-Nacetyltransferase (AAC) as co-target for drug desigining

The emergence of multidrug resistant tuberculosis (MDRTB) highlights the urgent need to understand the mechanisms of resistance to the drugs and to develop a new arena of therapeutics to treat the disease. Ethambutol, isonazid, pyrazinamide, rifampicin are first line of drugs against TB, whereas ami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Rakesh S, Jamdhade, Mahendra D, Sonawane, Mahesh S, Giri, Ashok P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2013
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602886/ https://www.ncbi.nlm.nih.gov/pubmed/23519100 http://dx.doi.org/10.6026/97320630009174

Ejemplares similares

in-silico study of arylalkylamine-nacetyltransferase enzyme to regulate circadian rhythmicity
por: Prashant, Kumar, et al.
Publicado: (2013)

Aminoglycoside antibiotics and autism: a speculative hypothesis
por: Manev, Radmila, et al.
Publicado: (2001)

Identification of potential leads against 4-hydroxytetrahydrodipicolinate synthase from Mycobacterium tuberculosis
por: Rehman, Ajijur, et al.
Publicado: (2016)

A Genomic Signature for Genotyping Mycobacterium tuberculosis
por: Tarazona, David, et al.
Publicado: (2017)

In silico identification and characterization of a hypothetical protein of Mycobacterium tuberculosis EAI5 as a potential virulent factor
por: Gupta, Debdoot, et al.
Publicado: (2016)

A rapid identification technique for drug-resistant Mycobacterium tuberculosis isolates using mismatch specific cleavage enzyme
por: Jaramillo, Luis, et al.
Publicado: (2018)

Identification of inhibitors against α-Isopropylmalate Synthase of Mycobacterium tuberculosis using docking-MM/PBSA hybrid approach
por: Pandey, Preeti, et al.
Publicado: (2017)

Aminoglycoside resistance profile and structural architecture of the aminoglycoside acetyltransferase AAC(6')-Im
por: Smith, Clyde A., et al.
Publicado: (2017)

Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis
por: Quiliano, Miguel, et al.
Publicado: (2011)

Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
por: Unissa, Ameeruddin Nusrath, et al.
Publicado: (2011)

Insight from the structural molecular model of cytidylate kinase from Mycobacterium tuberculosis
por: Verma, Nitin Kumar, et al.
Publicado: (2013)

Dataset of potential targets for Mycobacterium tuberculosis H37Rv through comparative genome analysis
por: Asif, Siddiqui M, et al.
Publicado: (2009)

Computational finding of potential inhibitor for Cytochrome P450 Mono-oxygenases Enzyme of Mycobacterium tuberculosis
por: Sharma, Ashwani, et al.
Publicado: (2012)

Insights from the protein-protein interaction network analysis of Mycobacterium tuberculosis toxin-antitoxin systems
por: Thakur, Zoozeal, et al.
Publicado: (2017)

Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
por: Ramirez, María S., et al.
Publicado: (2013)

Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis
por: Santhi, Natchimuthu, et al.
Publicado: (2011)

Insilico analysis and molecular docking of resuscitation promoting factor B (RpfB) protein of Mycobacterium tuberculosis
por: Mylliemngap, Baphilinia Jones, et al.
Publicado: (2012)

Insights from the predicted epitope similarity between Mycobacterium tuberculosis virulent factors and its human homologs
por: Gutlapalli, Venkata Ravi, et al.
Publicado: (2015)

Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification
por: Shanmugam, Anusuya, et al.
Publicado: (2010)

Designing novel inhibitors against Mycobacterium tuberculosis FadA5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds
por: Jaiswal, Atul Kumar, et al.
Publicado: (2018)

Insights from the docking and molecular dynamics simulation of the Phosphopantetheinyl transferase (PptT) structural model from Mycobacterium tuberculosis
por: Rohini, Karunakaran, et al.
Publicado: (2013)

Implication from the predicted docked interaction of sigma H and exploration of its interaction with RNA polymerase in Mycobacterium tuberculosis
por: Gupta, Aayatti Mallick, et al.
Publicado: (2015)

Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB
por: Brindha, Sridharan, et al.
Publicado: (2016)

Computational identification of composite regulatory sites in 16s-rRNA gene promoters of Mycobacterium species
por: Dwivedi, Neeraja, et al.
Publicado: (2008)

Structure based virtual screening to identify inhibitors against MurE Enzyme of Mycobacterium tuberculosis using AutoDock Vina
por: Singh, Shilpi, et al.
Publicado: (2014)

Insights from the analysis of predicted Rv0679c protein peptide from Mycobacterium tuberculosis with Toll like Receptors in host
por: Lavarti, Rupa, et al.
Publicado: (2016)

Structural basis for the in vitro known acyl-depsipeptide 2 (ADEP2) inhibition to Clp 2 protease from Mycobacterium tuberculosis
por: Khandekar, Natasha, et al.
Publicado: (2016)

DNA polymerase III α subunit from Mycobacterium tuberculosis H37Rv: Homology modeling and molecular docking of its inhibitor
por: Chhabra, Gagan, et al.
Publicado: (2011)

Molecular docking studies of benzimidazopyrimidine and coumarin substituted benzimidazopyrimidine derivatives: As potential human Aurora A kinase inhibitors
por: Chandra,, et al.
Publicado: (2014)

Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene aac(3)-IV
por: Plattner, Michel, et al.
Publicado: (2020)

Culture filtrate proteome analysis of aminoglycoside resistant clinical isolates of Mycobacterium tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2014)

A novel asymmetric-loop molecular beacon-based two-phase hybridization assay for accurate and high-throughput detection of multiple drug resistance-conferring point mutations in Mycobacterium tuberculosis
por: Chen, Qinghai, et al.
Publicado: (2012)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Aminoglycoside Susceptibility Profiles of Enterobacter cloacae Isolates Harboring the aac(6')-Ib Gene
por: Kim, Soo-Young, et al.
Publicado: (2011)

Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2′) enzymes
por: Bassenden, Angelia V., et al.
Publicado: (2021)

Aminoglycoside 6′-N-acetyltransferase Type Ib [AAC(6′)-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions
por: Reeves, Craig M., et al.
Publicado: (2020)

Isolation, purification and characterization of Cardiolipin synthase from Mycobacterium phlei {PRIVATE}
por: Sarma, Potukuchi Venkata Gurunadha Krishna, et al.
Publicado: (2013)

An improved hypergeometric probability method for identification of functionally linked proteins using phylogenetic profiles
por: Kotaru, Appala Raju, et al.
Publicado: (2013)

in Silico mutagenesis and docking studies of active site residues suggest altered substrate specificity and possible physiological role of Cinnamoyl CoA Reductase 1 (Ll-CCRH1)
por: Sonawane, Prashant, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rojq0qtfg1vijiiv2g2v9m4bn0